Filter
258
Filtered Results: 258
Text search:
contraceptive
discontinuation
Featured
Recommendations
26
New Publications
85
Language
Document type
No document type
176
Studies & Reports
43
Guidelines
34
Manuals
2
Fact sheets
2
Infographics
1
Countries / Regions
India
37
Kenya
13
Rwanda
13
Zambia
10
Nepal
8
Senegal
8
Bangladesh
8
Ethiopia
8
Namibia
7
Sierra Leone
6
Malawi
6
Zimbabwe
6
Philippines
6
Ghana
5
Nigeria
5
Cambodia
5
Tanzania
5
South Africa
5
Liberia
5
Uganda
4
Haiti
3
Latin America and the Carribbean
3
Indonesia
3
Myanmar / Burma
3
Lesotho
2
Benin
2
Burkina Faso
2
Jordan
2
Western and Central Europe
2
Egypt
2
Mali
2
Botswana
2
Somalia
2
Eswatini/ Swaziland
2
Tajikistan
1
Colombia
1
Albania
1
Peru
1
Global
1
Dominican Republic
1
Congo, Democratic Republic of
1
South–East Asia Region
1
East and Southern Africa
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
163
Clinical Guidelines
23
Women & Child Health
21
Capacity Building
14
Public Health
7
Key Resources
3
Pharmacy & Technologies
1
Toolboxes
HIV
32
TB
9
Mental Health
8
COVID-19
5
Pharmacy
5
NCDs
4
NTDs
3
Refugee
2
Conflict
2
Ebola & Marburg
1
Q8. SCOPING QUESTION: In people with bipolar disorders who require maintenance treatment, are a) antipsychotics or b) mood stabilizers (lithium, valproate or carbamazepine) effective and safe?
Clinical Guideline
Recommendations for a public health approach
2010 revision
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Septìeme Édition 2019
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
This clinical management manual for Ebola Viral Disease in Liberia was developed after several ETUs were established in the country following the outbreak early this year. As the outbreak evolved, it became evident that different SOPs were being used by clinicians across these treatment facilities. ...
A progress report
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
